OPY

OPY
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $424.438M ▲ | $41.909M ▲ | $21.712M ▲ | 5.115% ▼ | $2.06 | $63.599M ▼ |
| Q2-2025 | $373.178M ▲ | $41.782M ▼ | $21.674M ▼ | 5.808% ▼ | $2.06 ▼ | $64.216M ▼ |
| Q1-2025 | $367.825M ▼ | $42.191M ▲ | $30.655M ▲ | 8.334% ▲ | $2.93 ▲ | $72.056M ▲ |
| Q4-2024 | $375.417M ▲ | $41.749M ▲ | $10.729M ▼ | 2.858% ▼ | $1.04 ▼ | $47.835M ▼ |
| Q3-2024 | $373.352M | $40.842M | $24.508M | 6.564% | $2.37 | $68.879M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $38.288M ▲ | $3.818B ▲ | $2.898B ▲ | $920.274M ▲ |
| Q2-2025 | $37.618M ▲ | $3.687B ▲ | $2.79B ▲ | $896.858M ▲ |
| Q1-2025 | $36.696M ▲ | $3.572B ▲ | $2.7B ▲ | $872.266M ▲ |
| Q4-2024 | $33.15M ▲ | $3.383B ▲ | $2.532B ▲ | $850.395M ▲ |
| Q3-2024 | $32.242M | $3.367B | $2.529B | $837.838M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $21.712M ▲ | $63.423M ▲ | $641K ▲ | $-63.394M ▼ | $670K ▼ | $62.217M ▲ |
| Q2-2025 | $-30.655M ▼ | $40.069M ▲ | $-900K ▼ | $-38.247M ▼ | $922K ▼ | $38.942M ▲ |
| Q1-2025 | $30.655M ▲ | $-91.74M ▼ | $-359K ▲ | $95.645M ▲ | $3.546M ▲ | $-93.421M ▼ |
| Q4-2024 | $10.729M ▼ | $74.712M ▲ | $-4.294M ▼ | $-69.51M ▼ | $908K ▲ | $71.451M ▲ |
| Q3-2024 | $24.508M | $11.434M | $1.87M | $-14.276M | $-972K | $11.214M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Advisory Fees | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Investment Banking Advisory | $30.00M ▲ | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ |
Investment Banking Capital Markets | $10.00M ▲ | $20.00M ▲ | $20.00M ▲ | $60.00M ▲ |
Other | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Oppenheimer looks like a mature, relationship-driven financial firm that has been growing its revenue base and cautiously strengthening its balance sheet, but with profits and cash flows that remain meaningfully tied to market cycles. Its strengths lie in a diversified business model across wealth management and capital markets, a long-standing brand, specialist offerings, and a clear push to upgrade its digital platforms. On the other side, earnings volatility, uneven cash generation, and intense industry competition are ongoing challenges. Future performance will likely hinge on how well the firm can continue to recruit and retain top advisors, deepen client relationships, and leverage its technology investments to drive more stable, higher-quality earnings over time.
NEWS
November 24, 2025 · 8:00 AM UTC
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
Read more
November 17, 2025 · 6:00 AM UTC
Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and Trading
Read more
October 31, 2025 · 8:00 AM UTC
Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings
Read more
October 29, 2025 · 6:00 AM UTC
Oppenheimer Announces the Appointment of Public Finance Banker Guy T. Logan as Managing Director, Head of Infrastructure & Mid-Atlantic Region
Read more
October 6, 2025 · 6:00 AM UTC
Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
Read more
About Oppenheimer Holdings Inc.
https://www.oppenheimer.comOppenheimer Holdings Inc., through its subsidiaries, operates as a middle-market investment bank and full-service broker-dealer in the Americas, Europe, the Middle East, and Asia.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $424.438M ▲ | $41.909M ▲ | $21.712M ▲ | 5.115% ▼ | $2.06 | $63.599M ▼ |
| Q2-2025 | $373.178M ▲ | $41.782M ▼ | $21.674M ▼ | 5.808% ▼ | $2.06 ▼ | $64.216M ▼ |
| Q1-2025 | $367.825M ▼ | $42.191M ▲ | $30.655M ▲ | 8.334% ▲ | $2.93 ▲ | $72.056M ▲ |
| Q4-2024 | $375.417M ▲ | $41.749M ▲ | $10.729M ▼ | 2.858% ▼ | $1.04 ▼ | $47.835M ▼ |
| Q3-2024 | $373.352M | $40.842M | $24.508M | 6.564% | $2.37 | $68.879M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $38.288M ▲ | $3.818B ▲ | $2.898B ▲ | $920.274M ▲ |
| Q2-2025 | $37.618M ▲ | $3.687B ▲ | $2.79B ▲ | $896.858M ▲ |
| Q1-2025 | $36.696M ▲ | $3.572B ▲ | $2.7B ▲ | $872.266M ▲ |
| Q4-2024 | $33.15M ▲ | $3.383B ▲ | $2.532B ▲ | $850.395M ▲ |
| Q3-2024 | $32.242M | $3.367B | $2.529B | $837.838M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $21.712M ▲ | $63.423M ▲ | $641K ▲ | $-63.394M ▼ | $670K ▼ | $62.217M ▲ |
| Q2-2025 | $-30.655M ▼ | $40.069M ▲ | $-900K ▼ | $-38.247M ▼ | $922K ▼ | $38.942M ▲ |
| Q1-2025 | $30.655M ▲ | $-91.74M ▼ | $-359K ▲ | $95.645M ▲ | $3.546M ▲ | $-93.421M ▼ |
| Q4-2024 | $10.729M ▼ | $74.712M ▲ | $-4.294M ▼ | $-69.51M ▼ | $908K ▲ | $71.451M ▲ |
| Q3-2024 | $24.508M | $11.434M | $1.87M | $-14.276M | $-972K | $11.214M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Advisory Fees | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ |
Investment Banking Advisory | $30.00M ▲ | $30.00M ▲ | $20.00M ▼ | $20.00M ▲ |
Investment Banking Capital Markets | $10.00M ▲ | $20.00M ▲ | $20.00M ▲ | $60.00M ▲ |
Other | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Taken together, Oppenheimer looks like a mature, relationship-driven financial firm that has been growing its revenue base and cautiously strengthening its balance sheet, but with profits and cash flows that remain meaningfully tied to market cycles. Its strengths lie in a diversified business model across wealth management and capital markets, a long-standing brand, specialist offerings, and a clear push to upgrade its digital platforms. On the other side, earnings volatility, uneven cash generation, and intense industry competition are ongoing challenges. Future performance will likely hinge on how well the firm can continue to recruit and retain top advisors, deepen client relationships, and leverage its technology investments to drive more stable, higher-quality earnings over time.
NEWS
November 24, 2025 · 8:00 AM UTC
Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit
Read more
November 17, 2025 · 6:00 AM UTC
Oppenheimer & Co. Inc. Appoints Keith Peterson As Head of Cash Equity Sales and Trading
Read more
October 31, 2025 · 8:00 AM UTC
Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings
Read more
October 29, 2025 · 6:00 AM UTC
Oppenheimer Announces the Appointment of Public Finance Banker Guy T. Logan as Managing Director, Head of Infrastructure & Mid-Atlantic Region
Read more
October 6, 2025 · 6:00 AM UTC
Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking
Read more

CEO
Robert Steven Lowenthal
Compensation Summary
(Year 2024)

CEO
Robert Steven Lowenthal
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership

JB CAPITAL PARTNERS LP
503.954K Shares
$34.284M

DIMENSIONAL FUND ADVISORS LP
493.218K Shares
$33.554M

VANGUARD GROUP INC
426.033K Shares
$28.983M

BLACKROCK FUND ADVISORS
338.632K Shares
$23.037M

AMERICAN CENTURY COMPANIES INC
299.211K Shares
$20.355M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
192.571K Shares
$13.101M

BLACKROCK INC.
178.891K Shares
$12.17M

BLACKROCK, INC.
169.667K Shares
$11.542M

RBF CAPITAL, LLC
165K Shares
$11.225M

WEBER ALAN W
157.645K Shares
$10.725M

GREENWICH WEALTH MANAGEMENT LLC
125.022K Shares
$8.505M

ROYCE & ASSOCIATES LP
112.404K Shares
$7.647M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
91.348K Shares
$6.214M

MORGAN STANLEY
86.57K Shares
$5.889M

BOSTON PARTNERS
78.941K Shares
$5.37M

MILLENNIUM MANAGEMENT LLC
73.252K Shares
$4.983M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
72.884K Shares
$4.958M

MONARCH PARTNERS ASSET MANAGEMENT LLC
70.646K Shares
$4.806M

JPMORGAN CHASE & CO
69.438K Shares
$4.724M

GEODE CAPITAL MANAGEMENT, LLC
68.985K Shares
$4.693M
Summary
Only Showing The Top 20

